Lexicon Pharmaceuticals, Inc.
LXRXNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $722.13M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.10$2.68
- Volume (live)
- -
- Avg. volume (3M)
- 2.88M
Lexicon Pharmaceuticals (LXRX) Stock Price & Financial Analysis
Lexicon Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.62 - $1.68 |
|---|---|
| 52-Week High | $2.68 |
| 52-Week Low | $1.10 |
| Open | $1.63 |
| Volume (last close) | 1.43M |
| Average Volume (3M) | 2.88M |
| Revenue (TTM) | 41.47M |
|---|---|
| Net Income (TTM) | -61.12M |
| Free Cash Flow (TTM) | -79.72M |
| EPS (TTM) | −$0.16 |
| Profit Margin | -147.38% |
| Operating Margin | -131.43% |
| Return on Equity (ROE) | -35.02% |
| Debt to Equity | 0.34 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 722.13M |
|---|---|
| Shares Outstanding | 437.65M |
| Price to Sales (P/S) | 17.41 |
| Price to Book (P/B) | 4.14 |
| EV/EBITDA | -14.17 |
| 50-Day MA | $2.10 |
|---|---|
| 200-Day MA | $1.86 |
| 1-Year Change | +12.24% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Lexicon Pharmaceuticals at a Glance
As of the Oct 15, 2026 close, Lexicon Pharmaceuticals (LXRX) has a market capitalization of $722.13M. The stock trades at 17.4× sales. Over the trailing twelve months it lost $61.12M on revenue of $41.47M and burned $79.72M of free cash flow. Revenue fell 29.0% year over year.
As of its latest reported balance sheet, it holds $40.92M in cash and securities against $59.28M of debt, a net debt position of $18.36M.
Lexicon Pharmaceuticals does not currently pay a dividend.
The share price is up 12.2% over the past year. At $1.65 (the Oct 15, 2026 close) it sits within its 52-week range of $1.10 to $2.68, below its 200-day moving average of $1.86.
Frequently Asked Questions About Lexicon Pharmaceuticals
What is the current stock price for LXRX?
As of the Oct 15, 2026 close, LXRX stock trades at $1.65. The 52-week range is $1.10–$2.68, with a day range of $1.62–$1.68.
What is the P/E ratio for LXRX?
The P/E ratio (Price-to-Earnings) for LXRX is shown in the Key Statistics section. This valuation metric helps compare Lexicon Pharmaceuticals, Inc. to industry peers.
Does LXRX pay dividends?
Lexicon Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for LXRX?
Analyst ratings and recommendations for LXRX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of LXRX?
As of the Oct 15, 2026 close, Lexicon Pharmaceuticals's market capitalization is $722.1M, classifying it as a small-cap company. Lexicon Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.